The Impact of COVID-19 on Clinical Trial Conduct: The Importance of Considering Patient Stress, Coping and Perceptions

Erica Smith joined Tools4Patient as VP of Business Development in 2018. Dr. Smith received a Ph.D. in Biomedical Engineering from The University of Michigan in Ann Arbor.

Dr. Smith began her career in the pharmaceutical industry at Genetics Institute / Wyeth Research in Cambridge, MA and Pfizer in Groton, CT. Dr. Smith then worked for several CROs, developing a strong track record of sales leadership, strategic planning, developing and executing corporate growth strategies and marketing.

Dominique Demolle serves as Chief Executive Officer of Tools4Patient since its inception in 2013. Dr. Demolle holds a Ph.D. in Biochemistry from the University of Brussels. She joined the Clinical Research Group of GD Searle and then Eli Lilly. She has held positions with increasing leadership responsibilities at Eli Lilly and Company with the Lilly Indianapolis Clinical Research Unit in the US and the European Operational Staff management and ultimately became the Associate Director of Global Early Phase Operations. In 2007 she co-founded and successfully developed a Consulting Clinical Research Organization including partnerships with pharma and biotech before she left to set up Tools4Patient with previous colleagues.